4,0
6 gen 2015
Dipendente attuale, più di 8 anni
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
This is a unique company In that it is small enough to allow exposure to a lot areas in the pharmaceutical market but services large enough clients to gain an understanding of the entire market. Many who leave use it as a springboard to these larger companies. Having just been acquired by a public company there appears to be more individual opportunity although the change is somewhat chaotic. The CEO always reminds us that what we do matters.
Svantaggi
Change and a dynamic environment is not for everyone and many do not like this or survive. Senior management needs to be more aligned.